Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimou

Showing results (511-520 of 610) with videos related to

Pageof 61
Sort By:
The Pediatric Infectious Disease Journal|January 13, 2023
Decreasing Incidence of the Multisystem Inflammatory Syndrome in Children Over 3 Pandemic WavesIrini Eleftheriou, Despina Maritsi, Stavroula Lampidi, et al.
International Journal of Epidemiology|January 1, 2019
Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization studyXia Jiang, Niki L Dimou, Kawthar Al-Dabhani, et al.
The Oncologist|February 28, 2016
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensTheodoros P Vassilakopoulos, Maria N Dimopoulou, Maria K Angelopoulou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 21, 2021
Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization AnalysesNiki Dimou, Nagisa Mori, Sophia Harlid, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.
Nature Immunology|December 15, 2023
Human serous cavity macrophages and dendritic cells possess counterparts in the mouse with a distinct distribution between speciesJichang Han, Alexandre Gallerand, Emma C Erlich, et al.
Leukemia & Lymphoma|January 28, 2012
Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphomaMaria Dimou, Maria K Angelopoulou, Gerassimos A Pangalis, et al.
Cancer Medicine|March 22, 2019
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registryPanagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, et al.
Acta Neuropathologica|April 15, 2017
Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron lossMartin H Schludi, Lore Becker, Lillian Garrett, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trialMatthew S Block, Garth D Nelson, Jun Chen, et al.
Pageof 61

Showing results (511-520 of 610) with videos related to

Sort By:
Pageof 61
The Pediatric Infectious Disease Journal|January 13, 2023
Decreasing Incidence of the Multisystem Inflammatory Syndrome in Children Over 3 Pandemic WavesIrini Eleftheriou, Despina Maritsi, Stavroula Lampidi, et al.
International Journal of Epidemiology|January 1, 2019
Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization studyXia Jiang, Niki L Dimou, Kawthar Al-Dabhani, et al.
The Oncologist|February 28, 2016
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensTheodoros P Vassilakopoulos, Maria N Dimopoulou, Maria K Angelopoulou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 21, 2021
Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization AnalysesNiki Dimou, Nagisa Mori, Sophia Harlid, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanomaTina J Hieken, David Zahrieh, Thomas J Flotte, et al.
Nature Immunology|December 15, 2023
Human serous cavity macrophages and dendritic cells possess counterparts in the mouse with a distinct distribution between speciesJichang Han, Alexandre Gallerand, Emma C Erlich, et al.
Leukemia & Lymphoma|January 28, 2012
Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphomaMaria Dimou, Maria K Angelopoulou, Gerassimos A Pangalis, et al.
Cancer Medicine|March 22, 2019
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registryPanagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, et al.
Acta Neuropathologica|April 15, 2017
Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron lossMartin H Schludi, Lore Becker, Lillian Garrett, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trialMatthew S Block, Garth D Nelson, Jun Chen, et al.
Pageof 61